Clobetasol cream
کرم کلوبتازول
🧴 DermatologicalsSuper-high-potency topical corticosteroid
Market / country: 🇺🇸 USA
Temovate (US) · Dermovate (GB)
🧮 Dose calculator
Psoriasis and steroid-responsive dermatoses · Regimen source: FDA Clobetasol cream · Dosage and Administration
- • Super-high potency: max 2 consecutive weeks and less than 50 g per week. FDA Clobetasol cream · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to any component. FDA Clobetasol cream · Contraindications
- ⛔ Not recommended under 12 years. FDA Clobetasol cream · Pediatric Use
Formulations
- 0.05% cream — cream 🇺🇸 USA FDA Clobetasol cream · Dosage and Administration
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Clobetasol cream · Pregnancy
“Teratogenic Effects: Pregnancy Category C.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Clobetasol cream · Nursing Mothers
“Because many drugs are excreted in human milk, caution should be exercised when clobetasol propionate cream is administered to a nursing woman.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Clobetasol cream · Pediatric Use
“Safety and effectiveness of clobetasol propionate cream in pediatric patients have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Clobetasol cream · Geriatric Use
“A limited number of patients at or above 65 years of age have been treated with clobetasol propionate cream (n = 231) in US and non-US clinical trials.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA211256
- DailyMed (FDA label)FDA Clobetasol cream
- MedlinePlus (NIH)Clobetasol Topical
- WHO ATC/DDDD07AD01
- Darooyab (Iran)Clobetasol
🇮🇷 Registered in Iran Darooyab · G-2080/Clobetasol
Dosage forms with Iranian generic codes, per Darooyab.
- 03380 · CLOBETASOL PROPIONATE 0.05% 100G OINT · پماد کلوبتازول پروپیونات ۰٫۰۵ درصد ۱۰۰ گرم
- 00313 · CLOBETASOL PROPIONATE 0.05% 15G CREAM · کرم کلوبتازول پروپیونات ۰٫۰۵ درصد ۱۵ گرم
- 00314 · CLOBETASOL PROPIONATE 0.05% 15G OINT · پماد کلوبتازول پروپیونات ۰٫۰۵ درصد ۱۵ گرم
- 02425 · CLOBETASOL PROPIONATE 0.05% LOTION · لوسیون کلوبتازول پروپیونات ۰٫۰۵ درصد
- 51912 · CLOBETASOL PROPIONATE OINTMENT TOPICAL 0.05 % 100 g · پماد کلوبتازول پروپیونات ۰٫۰۵ درصد ۱۰۰ گرم
- 53058 · CLOBETASOL PROPIONATE LOTION TOPICAL 0.05 % 30 mL · لوسیون کلوبتازول پروپیونات ۰٫۰۵ درصد ۳۰ میلیلیتر
- 52978 · CLOBETASOL PROPIONATE OINTMENT TOPICAL 0.05 % 30 g · پماد کلوبتازول پروپیونات ۰٫۰۵ درصد ۳۰ گرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Clobetasol cream · Dosage and AdministrationFDA Clobetasol cream · ContraindicationsFDA Clobetasol cream · Pediatric UseFDA Clobetasol cream · PregnancyFDA Clobetasol cream · Nursing MothersFDA Clobetasol cream · Geriatric UseFDA Clobetasol cream · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-2080/Clobetasol
- Clinical review⚠ Unverified